Industries > Pharma > Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029

North America, Europe, India, Rest of the World (RoW)

PUBLISHED: 29 January 2019
PAGES: 207
PRODUCT CODE: PHA0352
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The top 10 generic drug producers have 61% share of the total revenue made by these top 50 companies. 22% of the top 50 generic drug producers are in North America. 30% of the top 50 generic drug producers fall under the RoW region. This figure reflects the increasing penetration of generics on a global scale with many pharmaceutical companies realising this industry as a primary source of revenue.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 207-page report you will receive 74 tables and 72 figures– all unavailable elsewhere.

The 207-page report provides clear detailed insight into the top 50 generic drug producers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• This report ranks the world’s top 50 generic drug manufacturers according to their generic drug revenues in 2017.

• Our report assesses the leading generic drug manufacturers worldwide. In general a company profile gives you the following information:
• Discussion of activities, technologies and recent financial results
• Assessment of developments – mergers and acquisitions (M&A), new products, outlooks, challenges and plans
• Historical revenue ($) and CAGR (%) of top players
• Forecasting of generic drug revenues to 2029 (for 18 leading companies).

• This report discusses the factors that affect the industry:
• M&A activity and related partnerships
• Global and regional strategies – extending business reach
• Competition from companies based in emerging national markets
• Increasing specialisation by leading players, including big pharma companies
• Increasing consolidation of the generics industry
• Advances in production technologies, including difficult-to-make generics and biosimilars – important shifts and opportunities in the industry.

• This report analyses the leading generic drug manufacturers in North America, including these companies:
• Abbott
• Akorn
• Alvogen
• Endo
• Impax
• Mallinckrodt
• Mylan
• Pfizer
• Pharmascience
• Valeant

• This report analyses the leading generic drug manufacturers in Europe, including these companies:
• Fresenius Kabi
• Gedeon Richter
• Insud Pharma
• Krka
• Novartis (Sandoz)
• Perrigo
• Pharmstandard
• Polpharma
• Sanofi
• Stada Arzneimittel

Top Generic Drug Producers Market Forecast 2019-2029

• This report analyses the leading generic drug manufacturers in India, including these companies:
• Sun Pharmaceuticals
• Aurobindo
• Lupin
• Cipla
• Dr Reddy’s
• Glenmark
• Torrent Pharma
• Cadila
• Wockhardt
• Ipca

• This report analyses the leading generic drug manufacturers in RoW, including these companies:
• Teva
• EMS
• Aspen
• Sawai Pharmaceutical
• Nichi-Iko
• Abdi Ibrahim
• Towa Pharmaceutical
• Eurofarma
• Taro Pharmaceutical
• Hypermarcas

Visiongain’s study is intended for anyone requiring commercial analyses for the top generic drug manufacturers. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029: North America, Europe, India, Rest of the World (RoW).

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top Generic Drug Producers Market Forecast 2019-2029


Latest Pharma news

“Global Influenza Vaccines Market Set to Grow to $4.9bn by 2024” says new Visiongain report

The global vaccines market is one that is driven by innovation. This is vital for maintaining the rich pipeline of vaccines seen in the human vaccines market.

05 July 2019

READ

“Pharmaceutical Wholesale & Distribution Organizations 2019 is estimated to reach $1.4bn in 2024” says Visiongain report

Opportunities in the market stem from the increasing use of specialist and generic drugs, which have higher profit margins; global expansion into the emerging markets; vertical integration of wholesalers; and the increasing use of pharmaceuticals.

28 June 2019

READ

“Global Vaccines Sales market set to grow to $75bn by 2024” says new Visiongain report

Progress in R&D in the therapeutic vaccine field will yield revolutionary results and answer unmet medical needs. This will also lead to more innovative approaches to vaccine development.

25 June 2019

READ

“Global Inflammatory Bowel Diseases (IBD) Drug Market is estimated to reach $8.6bn by 2024” says new Visiongain report

Revenue growth will be driven by rising incidence and prevalence owing to modern lifestyles and improved awareness and diagnosis.

21 June 2019

READ

Categories

Category